This article reviews sources of excipient variability, including raw materials and processing, both of which may vary from supplier to supplier and from plant to plant for a single manufacturer.
Joseph Zeleznik
Advertisement
Joseph Zeleznik is manager, technical & regulatory affairs at Meggle USA.
Articles by Joseph Zeleznik
This article seeks to promote dialogue among stakeholders to facilitate consensus regarding requirements for excipients.
Advertisement
Latest Updated Articles
Mitigating the Risk from Excipient VariabilityAugust 2nd 2022
The Real Complexity of Excipient CompositionOctober 2nd 2017
Advertisement
Advertisement
Trending on Pharmaceutical Technology
1
Signs Point to FDA Shelving Priority Voucher Pilot, Stalling Fast-Track Drug Reviews
2
France Remains One of Europe’s Leading Biotech Funding Hubs
3
CPHI Milan Future Leader Award Winner: Pauline van der Wijst-Janssen
4
The Impact of Excipients on Continuous Manufacturing and the Risk of Nitrites
5